Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Free Cash Flow (2020 - 2026)

Biomea Fusion (BMEA) posted Free Cash Flow of -$11.7 million for Q1 2026, up 12.41% sequentially from -$13.3 million in Q4 2025, and up 54.54% YoY from -$7.6 million in Q1 2025.

Biomea Fusion (BMEA) Free Cash Flow (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Free Cash Flow for 7 years, with the latest figure at -$11.7 million in Q1 2026.

  • Quarterly Free Cash Flow rose 54.54% year-over-year to -$11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.8 million (up 48.67% YoY) and the FY2025 annual result came in at -$69.8 million, up 39.35% from the prior year.
  • Free Cash Flow advanced to -$11.7 million in Q1 2026 per BMEA's latest filing, from -$13.3 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$10.1 million in Q1 2022 and troughed at -$32.7 million in Q2 2024.
  • A 5-year average of -$21.1 million and a median of -$21.8 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2026: Free Cash Flow slumped 167.12% in 2023, then jumped 54.54% in 2026.
  • Over 5 years, Free Cash Flow stood at -$20.9 million in 2022, then decreased by 4.4% to -$21.8 million in 2023, then slipped by 13.77% to -$24.8 million in 2024, then soared by 46.36% to -$13.3 million in 2025, then grew by 12.41% to -$11.7 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$11.7 million, -$13.3 million, and -$11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -10.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.03 Mn
Jun 30, 2026 -10.03 Mn
Mar 31, 2026 -11.67 Mn
Mar 31, 2026 -11.67 Mn
Dec 31, 2025 -13.32 Mn
Dec 31, 2025 -13.32 Mn
Sep 30, 2025 -11.55 Mn
Sep 30, 2025 -11.55 Mn
Jun 30, 2025 -19.21 Mn
Jun 30, 2025 -19.21 Mn
Mar 31, 2025 -25.67 Mn
Mar 31, 2025 -25.67 Mn
Dec 31, 2024 -24.84 Mn
Dec 31, 2024 -24.84 Mn
Sep 30, 2024 -25.40 Mn
Sep 30, 2024 -25.40 Mn
Jun 30, 2024 -32.70 Mn
Jun 30, 2024 -32.70 Mn
Mar 31, 2024 -32.07 Mn
Mar 31, 2024 -32.07 Mn